NexImmune, Inc. (NASDAQ:NEXI – Get Free Report) dropped 12.5% during mid-day trading on Thursday . The stock traded as low as $0.21 and last traded at $0.21. Approximately 808 shares were traded during mid-day trading, a decline of 100% from the average daily volume of 941,791 shares. The stock had previously closed at $0.24.
NexImmune Price Performance
The company has a market capitalization of $287,910.00, a P/E ratio of -0.01 and a beta of 1.78. The company has a 50 day moving average of $0.69 and a 200-day moving average of $2.46.
About NexImmune
NexImmune, Inc, a clinical-stage biotechnology company, engages in developing therapies with curative potential for patients with cancer and other life-threatening immune-mediated diseases in the United States. It develops approaches to T cell immunotherapies based on its proprietary Artificial Immune Modulation, a nanoparticle technology platform.
See Also
- Five stocks we like better than NexImmune
- Consumer Discretionary Stocks Explained
- When Is the Best Time to Invest in Mutual Funds?
- Are These Liquid Natural Gas Stocks Ready For An Upside Bounce?
- Is NVIDIA Stock in a Correction or Consolidation?
- Overbought Stocks Explained: Should You Trade Them?
- 3 Oversold Stocks with Big RSI Rebound Potential
Receive News & Ratings for NexImmune Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NexImmune and related companies with MarketBeat.com's FREE daily email newsletter.
